April brings unprecedented stock volatility as investors face huge swings. Key players like Tesla and Apple react to macroeconomic pressures, reshaping market dynamics.
Explore BioNTech SE's Form 6-K filing detailing strategic priorities and updates from the 2025 J.P. Morgan Healthcare Conference, enhancing transparency for investors.
Explore BioNTech SE's financial report detailing a $467M royalty settlement with the University of Pennsylvania, including Pfizer's $170M reimbursement and key agreement terms.
Explore BioNTech SE's Form 6-K report detailing a $791.5M settlement with the NIH over COVID-19 vaccine royalties and new licensing terms effective January 2024.